Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-07

Clinical Trial Update: Detecting CREPT in Urine for Bladder Cancer Diagnosis and Monitoring

View source ↗

Summary

A clinical trial is recruiting to evaluate measuring CREPT protein levels in urine as a noninvasive method to diagnose and monitor bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Bladder Cancer | Status: RECRUITING